We next demonstrated that shRNA-mediated SMARCB1 KD significantly reduced in vitro proliferation (Fig. 5b) and in vivo tumor growth using a human CRC cell line xenograft (Fig. 5c and Supplementary Fig. 5b). Here, SMARCB1 is linked to neoplasm.